Survival in patients with esophageal adenocarcinoma undergoing trimodality therapy is independent of regional lymph node location presented at the sixty-first annual meeting of the southern thoracic surgical association, Tucson, AZ, Nov 5-8, 2014.

Annals of Thoracic Surgery

Volumn 101, Issue 3, 2016, Pages 1075-1081

  Sepesi, Boris ^a   Schmidt, Henner E ^b   Lada, Michal ^c   Correa, Arlene M ^a   Walsh, Garrett L ^a   Mehran, Reza J ^a   Rice, David C ^a   Roth, Jack A ^a   Vaporciyan, Ara A ^a   Ajani, Jaffer A ^a   Watson, Thomas J ^c   Swisher, Stephen G ^a   Low, Donald E ^b   Hofstetter, Wayne L ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b VIRGINIA MASON MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; PLATINUM;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CELIAC LYMPH NODE; CONFERENCE PAPER; ESOPHAGEAL ADENOCARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LOWER ESOPHAGEAL LYMPH NODE; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PARATRACHEAL LYMPH NODE; PERIGASTRIC LYMPH NODE; PERIHEPATIC LYMPH NODE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBCARINAL LYMPH NODE; SUPRACLAVICULAR LYMPH NODE; TUMOR LOCALIZATION; ADENOCARCINOMA; ANALYSIS OF VARIANCE; CAUSE OF DEATH; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS RESECTION; FOLLOW UP; GASTROESOPHAGEAL JUNCTION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SURGERY; SURVIVAL ANALYSIS; TUMOR INVASION; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CAUSE OF DEATH; COHORT STUDIES; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84958675635     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2015.09.063     Document Type: Conference Paper

References (16)

1. T.W. Rice, E.H. Blackstone, and V.W. Rusch 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction Ann Surg Oncol 17 2010 1721 1724
2. K.M. Sjoquist, B.H. Burmeister, B.M. Smithers, et al. Australasian Gastro-Intestinal Trials Group Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis Lancet Oncol 12 2011 681 692
3. A.G. Little, A.E. Lerut, D.H. Harpole, and et al. The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction Ann Thorac Surg 98 2014 1880 1885
4. M. Stahl, M.K. Walz, M. Stuschke, and et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 12 2009 851 856
5. D. Cunningham, W.H. Allum, S.P. Stenning, and et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 2006 11 20
6. P. van Hagen, M.C. Hulshof, J.J. van Lanschot, et al. CROSS Group Preoperative chemoradiotherapy for esophageal or junctional cancer N Engl J Med 366 2012 2074 2084
7. J. Tepper, M.J. Krasna, D. Niedzwiecki, and et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781 J Clin Oncol 26 2009 1086 1092
8. M. Stahl, M. Stuschke, N. Lehmann, and et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus J Clin Oncol 23 2005 2310 2317
9. N.P. Rizk, H. Ishwaran, T.W. Rice, and et al. Optimum lymphadenectomy for esophageal cancer Ann Surg 251 2010 46 50
10. C.G. Peyre, J.A. Hagen, S.R. DeMeester, and et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection Ann Surg 248 2008 549 556
11. C.G. Peyre, J.A. Hagen, S.R. DeMeester, and et al. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes Ann Surg 248 2008 979 985
12. N.K. Altorki, X.K. Zhou, B. Stiles, and et al. Total number of resected lymph nodes predicts survival in esophageal cancer Ann Surg 248 2008 221 226
13. J.J. Boonstra, L.B. Koppert, B.P. Wijnhoven, and et al. Chemotherapy followed by surgery in patients with carcinoma of the distal esophagus and celiac lymph node involvement J Surg Oncol 100 2009 407 413
14. A.M. Francis, B. Sepesi, A.M. Correa, et al. University of Texas MD Anderson Esophageal Cancer Group The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma Ann Surg 258 2013 500 507
15. J.J. Erasmus, R.F. Munden, M.T. Truong, and et al. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging J Thorac Oncol 1 2006 478 486
16. B. Klaeser, E. Nitzsche, J.C. Schuller, and et al. Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02) Onkologie 32 2009 724 730